Efficacy of polymeric encapsulated C5a peptidase-based group B streptococcus vaccines in a murine model

Encapsulated C5a peptidase elicited significant immune responses and protection against a GBS challenge. C5a peptidase microsphere encapsulation has potential as a GBS vaccine.